Author
Listed:
- Belen Sotomayor
(Cornell University)
- Thomas C. Donahue
(Cornell University
University of Maryland)
- Sai Pooja Mahajan
(Johns Hopkins University)
- May N. Taw
(Cornell University)
- Sophia W. Hulbert
(Cornell University)
- Erik J. Bidstrup
(Cornell University)
- D. Natasha Owitipana
(University of Maryland)
- Alexandra Pang
(Cornell University)
- Xu Yang
(315 Riverbend Road)
- Souvik Ghosal
(Cornell University)
- Christopher A. Alabi
(Cornell University
Cornell University)
- Parastoo Azadi
(315 Riverbend Road)
- Jeffrey J. Gray
(Johns Hopkins University)
- Michael C. Jewett
(Stanford University)
- Lai-Xi Wang
(University of Maryland)
- Matthew P. DeLisa
(Cornell University
Cornell University
Cornell University
130 Biotechnology Building)
Abstract
Human immunoglobulin G (IgG) antibodies are a major class of biotherapeutics and undergo N-linked glycosylation in their Fc domain, which is critical for immune functions and therapeutic activity. Hence, technologies for producing authentically glycosylated IgGs are in high demand. Previous attempts to engineer Escherichia coli for this purpose have met limited success due in part to the lack of oligosaccharyltransferase (OST) enzymes that can install N-glycans at the conserved N297 site in the Fc region. Here, we identify a single-subunit OST from Desulfovibrio marinus with relaxed substrate specificity that catalyzes glycosylation of native Fc acceptor sites. By chemoenzymatic remodeling the attached bacterial glycans to homogeneous, asialo complex-type G2 N-glycans, the E. coli-derived Fc binds human FcγRIIIa/CD16a, a key receptor for antibody-dependent cellular cytotoxicity (ADCC). Overall, the discovery of D. marinus OST provides previously unavailable biocatalytic capabilities and sets the stage for using E. coli to produce fully human antibodies.
Suggested Citation
Belen Sotomayor & Thomas C. Donahue & Sai Pooja Mahajan & May N. Taw & Sophia W. Hulbert & Erik J. Bidstrup & D. Natasha Owitipana & Alexandra Pang & Xu Yang & Souvik Ghosal & Christopher A. Alabi & P, 2025.
"Discovery of a single-subunit oligosaccharyltransferase that enables glycosylation of full-length IgG antibodies in bacteria,"
Nature Communications, Nature, vol. 16(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61440-7
DOI: 10.1038/s41467-025-61440-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61440-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.